|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||
| Depreciation, amortization and accretion | |||||
| Impairments and net losses on disposal of long-lived assets | |||||
| Share-based compensation | |||||
| Deferred income taxes | |||||
| Gain on sales of businesses, net | |||||
| Loss (gain) on sales of marketable securities and restricted marketable securities | |||||
| Liabilities assumed by customers for the sale of systems | |||||
| Gain on debt forgiveness | |||||
| Other, net | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable, trade | |||||
| Inventories | |||||
| Project assets and PV solar power systems | |||||
| Government grants receivable | |||||
| Other assets | |||||
| Income tax receivable and payable | |||||
| Accounts payable and accrued expenses | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Purchases of marketable securities and restricted marketable securities | |||||
| Proceeds from sales and maturities of marketable securities | |||||
| Proceeds from sales of businesses, net of cash and restricted cash sold | |||||
| Acquisitions, net of cash acquired | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from borrowings under debt arrangements, net of issuance costs | |||||
| Repayment of debt | |||||
| Proceeds from other borrowings | |||||
| Repayments of other borrowings | |||||
| Payments of tax withholdings for restricted shares | |||||
| Contingent consideration payment and other financing activities | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents | |||||
| Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents | |||||
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of the period | |||||
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of the period | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Property, plant and equipment acquisitions funded by liabilities | |||||
| Proceeds to be received from asset-based government grants | |||||
| Acquisitions funded by contingent consideration | |||||
Loading...